Previous studies have demonstrated that CTHRC1 activates HIF-α pathway and contributes to tumor angiogenesis in hepatocellular carcinoma and pancreatic cancer (Zhang et al., 2015; Lee et al., 2016). Here, CTHRC1 is linked to familial pancreatic carcinoma.